HAMBURG, Germany — A combination of the antiviral drugs pleconaril and ribavirin slowed the decline of pancreatic insulin production compared with placebo in children and adolescents with newly ...

A prospective cohort study found that diabetes and insulin resistance were the strongest risk factors for premature onset of coronary heart disease (CHD) among American women. Results were published ...

Doctors hailed the FDA approval as a "watershed moment." For the first time, the U.S. Food and Drug Administration on Thursday approved a treatment that can delay the onset of Type 1 diabetes.

Please provide your email address to receive an email when new articles are posted on . Diabetes and insulin resistance appeared to be the strongest determinants for premature onset of CHD in women, ...

This week, the FDA approved a new treatment called teplizumab that delays the onset of type 1 diabetes. TZIELD, the brand name, will total $193,000 over the 14-day treatment. Experts say the new ...

SIOUX FALLS, S.D. (KELO) — The FDA approved a new drug called Teplizumab that can delay the onset of Type 1 Diabetes, especially in children. Sanford researchers dedicated to finding a cure say this ...

Researchers identify genetic markers that predict the rate of β-cell failure in type 1 diabetes, facilitating earlier, personalized care strategies Type 1 diabetes (T1D) is an autoimmune condition ...

Please provide your email address to receive an email when new articles are posted on . A supplement of Vitamin D2 may improve insulin sensitivity and slow the increase of HbA1c for children and ...

A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...